Related Experiment Video
Updated: Sep 15, 2025

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
Published on: April 29, 2015
T Cell Response Evaluation After A Fifth Dose of an Inactivated SARS-CoV-2 Vaccine Using Multiparametric Flow
Francisca Román1, Antonia Reyes1, Cristián Gutiérrez2
1Millennium Institute on Immunology and Immunotherapy, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.
T cell responses are vital for COVID-19 immunity from SARS-CoV-2 vaccines. Multiparametric flow cytometry effectively analyzes T cell changes after booster vaccinations, like a fifth inactivated vaccine dose.
Area of Science:
- Immunology
- Vaccinology
Background:
- T cell-mediated immunity is crucial for protection against SARS-CoV-2 infection.
- Booster vaccinations enhance adaptive immune responses to viral threats.
- Understanding T cell dynamics post-vaccination is key to optimizing vaccine strategies.
Purpose of the Study:
- To investigate the T cell response following a fifth dose of an inactivated SARS-CoV-2 vaccine.
- To evaluate the utility of multiparametric flow cytometry in assessing vaccine-induced T cell phenotypes.
Main Methods:
- Multiparametric flow cytometry was employed to analyze T cell phenotypes.
- Immune responses were assessed after administration of a fifth dose of an inactivated SARS-CoV-2 vaccine.
Main Results:
- Multiparametric flow cytometry provided detailed insights into T cell phenotype alterations.
- Specific T cell subset changes were observed following the booster vaccination.
Conclusions:
- Multiparametric flow cytometry is a powerful tool for dissecting vaccine-induced T cell immunity.
- Further characterization of T cell responses can inform future vaccine development and administration schedules.
More Related Videos
09:37Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
09:03Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
Published on: June 19, 2018